Doxycycline Improves Outcomes of Early Syphilis in Patients With HIV
Researchers assessed whether the addition of doxycycline to benzathine penicillin G for early syphilis treatment improves serologic outcomes in patients with HIV infection.
Diagnosis & Disease Information
Update to Guidelines for Treatment and Management of PCOS Using Combined Oral Contraceptive Pills
Investigators assessed the use of different combined oral contraceptive pills for the treatment and management of polycystic ovary syndrome, as an update to recent evidence-based guidelines.
5 Things to Know About the New Drug Pricing Negotiations
The Biden administration unveiled the first 10 drugs subject to price negotiations, taking a swipe at the pharmaceutical industry. But what does it mean for patients?
Have Biologics Been Effective in Treating Ulcerative Colitis?
What have we learned in recent years about the safety and efficacy of different biologics for the treatment of ulcerative colitis?
Does Continuous Meropenem Administration Improve Clinical Outcomes in Sepsis?
Researchers compared outcomes of continuous vs intermittent meropenem among critically ill patients with sepsis.
Pitavastatin Cuts Risk of Cardiovascular Events in Patients With HIV
Significant reduction seen in incidence of major adverse cardiovascular event over median follow-up of 5.1 years.
.
Glucose-Lowering Medications Reduce CV Risk in Hispanic Patients With Diabetes
Researchers sought to examine the effect of glucose-lowering medications on cardiovascular and renal outcomes in Hispanic patients.
Pfizer Warns of Looming Shortage of Long-Acting Penicillin for Children
Company says there is impending shortages of Bicillin, with pediatric versions of the shot likely to run out by the end of June.
Switching Biologics Common Among Patients With Psoriasis
Researchers sought to assess switch rates in patients who initiated use of biologics for psoriasis during a 24-month period.
Bladder Cancer Treatment May Lower Risk for Alzheimer and Related Dementias
Greater effect seen for patients aged 70 years and older at time of bacillus Calmette-Guerin vaccination.
- Loading...
Loading...
Next post in Oncology Information Center
Loading... 
Loading...